- Home
- TROO vs SCLXW Comparison
TROO vs SCLXW Comparison
Compare TROO & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TROO
- SCLXW
- Stock Information
- Founded
- TROO 2005
- SCLXW N/A
- Country
- TROO Hong Kong
- SCLXW United States
- Employees
- TROO N/A
- SCLXW 111
- Industry
- TROO Radio And Television Broadcasting And Communications Equipment
- SCLXW Biotechnology: Pharmaceutical Preparations
- Sector
- TROO Technology
- SCLXW Health Care
- Exchange
- TROO Nasdaq
- SCLXW Nasdaq
- Market Cap
- TROO N/A
- SCLXW N/A
- IPO Year
- TROO N/A
- SCLXW N/A
- Fundamental
- Price
- TROO $0.83
- SCLXW $0.56
- Analyst Decision
- TROO
- SCLXW
- Analyst Count
- TROO 0
- SCLXW 0
- Target Price
- TROO N/A
- SCLXW N/A
- AVG Volume (30 Days)
- TROO 407.8K
- SCLXW 4.0K
- Earning Date
- TROO 08-26-2025
- SCLXW 03-07-2025
- Dividend Yield
- TROO N/A
- SCLXW N/A
- EPS Growth
- TROO N/A
- SCLXW N/A
- EPS
- TROO N/A
- SCLXW N/A
- Revenue
- TROO $10,073,000.00
- SCLXW $55,152,000.00
- Revenue This Year
- TROO N/A
- SCLXW N/A
- Revenue Next Year
- TROO N/A
- SCLXW N/A
- P/E Ratio
- TROO N/A
- SCLXW N/A
- Revenue Growth
- TROO 182.24
- SCLXW 22.02
- 52 Week Low
- TROO $0.49
- SCLXW $0.18
- 52 Week High
- TROO $4.89
- SCLXW $0.18
- Technical
- Relative Strength Index (RSI)
- TROO 53.50
- SCLXW N/A
- Support Level
- TROO $0.75
- SCLXW N/A
- Resistance Level
- TROO $0.99
- SCLXW N/A
- Average True Range (ATR)
- TROO 0.08
- SCLXW 0.00
- MACD
- TROO 0.01
- SCLXW 0.00
- Stochastic Oscillator
- TROO 49.63
- SCLXW 0.00
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.